SterileAtlas Marketplaces

DiscoveryAcademic Preclinical Labs Process Dev (PDO)CDMOs

ClinicalCROs Clinical Sites Ethics / IRB Central Labs

QualityPharmacovigilance Regulatory Engineering Consultants

SupplySuppliers Equipment Packaging

DistributionLogistics Distribution Specialty Pharmacy

AccessPayers PBM

CapitalInvestors IP & Legal

SterileAtlasIntelligence Mission Control

Loading…

SterileAtlas

One marketplace for the entire drug lifecycle — global sterile pharmaceutical & biotech manufacturing intelligence.

Marketplaces

All 22 marketplaces
CDMOs
CROs
Clinical trial sites
Consultants

Opportunities

Projects, jobs & leads
Open projects
Jobs
Consulting leads

Platform

Pricing
About us
List your company
Mission Control

© 2026 SterileAtlas · Capability scores are deterministic, rules-based — not AI.

About us Terms Usage Policy Disclosures Compliance Community guidelines Privacy Cookies Refunds DPA Trust & security

Data shown across the platform is illustrative and unverified — not for vendor qualification or regulatory use.

Market Access & Reimbursement

Payers

Coverage, formulary & market access

19

payers listed

Health plans, coverage, formulary and market-access partners — the reimbursement path your launch depends on.

SearchFaceted, over real records CompareSide-by-side scorecards Post an RFxGet qualified responses CollaborateRun it in a shared room AI assistantYour organisation, this market

Scores are deterministic, rules-based — not AI.

MarketplacesPayers

19 payers

Sort

Coverage reach Formulary strength Reimbursement capability Value contracting Access efficiency Compliance maturity Name (A–Z)

Therapeutic focus

Cardiometabolic19 Oncology18 Primary care11 Immunology10 Rare disease9 Specialty7 Cell & gene therapy3 Infectious disease3 Neurology1 Other1

Contracting

Value-based contracting Risk sharing Outcomes-based Budget-impact modeling Real-world evidence

Access management

Prior authorization Step therapy Coverage determination Appeals management Digital portal

Coverage focus

Oncology Cell & gene therapy Rare disease Biologics Vaccines Specialty drug

Status

Verified Accepting partners

Formulary structure

Managed7 Open6 Tiered5 Closed1

Ownership

Public9 Government6 Mutual3 Private1

Formulary win rate

Any win rate ≥ 50% formulary wins ≥ 55% formulary wins ≥ 60% formulary wins ≥ 65% formulary wins

Approval rate

Any approval rate ≥ 82% approval ≥ 85% approval ≥ 88% approval

Network size

Any network size ≥ 250k providers ≥ 500k providers ≥ 1M providers

Appeal success

Any appeal success ≥ 30% appeals upheld ≥ 35% appeals upheld ≥ 40% appeals upheld

Country

China France Germany Japan Spain USA United Kingdom

Showing 4 of 19Clear filters Cell & gene therapy Neurology

UnitedHealth Group

Managed Care Organization · Minnetonka, MN, USA

50reach

OncologyRare diseaseImmunologyCardiometabolic

Value-basedSpecialtyCMSMedicareMedicaid

FORM 75REIMB 1002 locations

Accepting partnersRegional

NHSA

National Healthcare Security Administration

Government Program · Beijing, China

43reach

OncologyRare diseaseCell & gene therapyImmunology

Value-basedSpecialtyNRDL (China)NMPAHTA

FORM 75REIMB 792 locations

Accepting partnersRegional

Techniker Krankenkasse (TK)

Techniker Krankenkasse (TK)

National Health Insurer · Hamburg, Germany

43reach

OncologyRare diseaseCell & gene therapyImmunology

Value-basedSpecialtyHTAGDPR

FORM 75REIMB 792 locations

Accepting partnersRegional

HUM

Medicare Plan · Louisville, KY, USA

37reach

CardiometabolicOncologyPrimary careNeurology

Value-basedSpecialtyCMSMedicareMedicaid

FORM 43REIMB 932 locations

Accepting partnersFocused